Author:
Kotova O. V.,Medvedev V. E.,Poluektov M. G.,Belyaev A. A.,Akarachkova E. S.
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. F. J. Carod-Artal, “Neurological complications of coronavirus and COVID-19,” Rev. Neurol., 1, No. 9, 311–322 (2020), 10.33588/rn.7009.2020179.
2. Office for National Statistics (ONS), The Prevalence of Long COVID Symptoms and COVID-19 Complications, updated April 30, 2021, https://www.ons.gov.uk/news/statementsandletters/the prevalenceoflong covid symptoms and covid19 complications.
3. M. Cortes Rivera, C. Mastronardi, C. T. Silva-Aldana, et al., “Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review,” Diagnostics (Basel), 9, No. 3, 91 (2019), https://doi.org/10.3390/diagnostics9030091.
4. R. Lu, X. Zhao, J. Li, et al., “Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding,” Lancet, 395, No. 10224, 565–574 (2020), https://doi.org/10.1016/S0140-6736(20)30251-8.
5. H. Ahmed, K. Patel, D. C. Greenwood, et al., “Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis,” J. Rehabil. Med., 31, 52, No. 5, jrm00063 (2020), https://doi.org/10.2340/16501977-2694.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献